Wegovy Pill vs Injection: Results, Dosing and Price

Semaglutide is the same active molecule whether you swallow it or inject it — but the two delivery methods are not interchangeable, and they have not been studied for all the same uses. If you are weighing a daily pill against a weekly shot, here is what the evidence and the labels actually say, in plain language.

Wegovy pill vs injection at a glance

Manufacturer price snapshot: October 4, 2026; confirm current eligibility, dose and offer conditions before paying. The weight-loss analyses include the effects of treatment discontinuation, but the trials were separate: their percentages do not establish equivalence or show that one formulation is better for you. For every form's price in one table, see what semaglutide costs.

The two forms

Semaglutide is available in weekly injections and daily tablets. Wegovy has both forms for weight management and cardiovascular risk reduction in eligible populations. Rybelsus and the distinct Ozempic tablets are approved for glycemic control and cardiovascular risk reduction in eligible adults with type 2 diabetes; they are not weight-management substitutes for Wegovy.^5,8 Ozempic is also an injection brand, so always specify the dosage form.

The current tablet label distinguishes Rybelsus 3/7/14 mg from Ozempic tablets 1.5/4/9 mg and says they are not substitutable milligram for milligram. Neither should be substituted for a Wegovy tablet or an injection without the prescriber's product-specific instructions.⁸

What the oral evidence shows

The tablet is not a watered-down version with no data behind it. Oral semaglutide was tested in a large program of trials called PIONEER. PIONEER 1 was the registration study showing that oral semaglutide, taken on its own, lowered blood sugar effectively compared with placebo in people with type 2 diabetes¹. The PIONEER 6 cardiovascular outcomes trial then showed that oral semaglutide was non-inferior to placebo for major cardiovascular events — a reassuring safety signal for the heart². The current Rybelsus/Ozempic tablet label additionally includes major cardiovascular event reduction for adults with type 2 diabetes at high risk; the historical PIONEER 6 safety finding is not the limit of its current indication.⁸ More recent PIONEER trials confirmed efficacy and safety in additional populations, broadening the evidence base for the tablet³.

So the oral form is genuinely well-studied for diabetes. Until December 2025 it lacked the dedicated weight-management approval the injectable (Wegovy 2.4 mg, studied in STEP 1) had⁴; the 25 mg Wegovy pill, tested in OASIS 4, closed that gap⁶. If weight loss is specifically why you are asking about the pill, we dig into exactly what Rybelsus can and can't do in Rybelsus (Oral Semaglutide): Does the Pill Work for Weight Loss?.

Daily pill vs weekly shot

The most obvious difference is frequency and method. The injection is once a week, which many people find simpler to remember. The tablet is once a day — and it comes with strict rules: it has to be taken on an empty stomach with up to four ounces of water, then at least 30 minutes before food, other drinks or oral medicines.^5,8 Skipping those rules can reduce how much drug your body absorbs. (Orforglipron, sold as Foundayo, is a different GLP-1 pill without those rules; see how Foundayo compares with the Wegovy pill.) Some telehealth brands also sell a compounded daily tablet — Dollar Dad Club lists one beside its injection — which is neither the Wegovy pill nor Rybelsus, so ask the prescriber exactly how it should be taken.

There is also a difference in how the dose is built up. The FDA labels describe gradual titration for both forms to limit side effects — for the injection, the weekly dose is stepped up over weeks toward the maintenance level⁵. The reason is the same in both cases: easing in keeps gastrointestinal side effects more tolerable. We cover that schedule in detail in Semaglutide Dosing & Side Effects. If you choose the weekly shot, our step-by-step on how to inject Wegovy covers the manufacturer pen, injection sites and storage. Those directions should not be used to measure a compounded vial dose.

For a daily-pill schedule, see the oral semaglutide morning routine. Semaglutide and levothyroxine covers a specifically measured oral-drug interaction and the competing fasting requirements.

Side effects: largely the same family

Because it is the same molecule acting on the same GLP-1 receptors, the side-effect profile is broadly similar across forms — nausea, vomiting, diarrhea, and constipation are the most common, and they tend to ease over time. Both forms are prescription-only and share major warnings, but rates and formulation-specific advice differ.⁵ For example, the SNAC-containing tablets have a breastfeeding warning distinct from the injection discussion; see semaglutide and breastfeeding. Neither is a "gentler" option in the sense of skipping side effects; the tolerability mostly comes down to titrating sensibly and following the dosing rules.

Dose strength and what's been studied

It is worth knowing that the doses are not directly comparable milligram-for-milligram between forms, because absorption differs. The injectable delivers semaglutide straight under the skin, while the tablet has to survive the stomach, so the tablet uses different dose strengths to achieve a comparable effect. STEP 1 studied 2.4 mg weekly injection, while OASIS 4 studied 25 mg daily tablets.^4,6 Those trial regimens are not interchangeable milligram for milligram. The current Wegovy label recommends 25 mg daily tablet maintenance and lists 2.4 mg weekly injection as recommended adult weight-management maintenance, with 1.7 mg permitted. For eligible adults tolerating 2.4 mg for at least four weeks who need additional weight reduction, a clinician may increase the injection to 7.2 mg.⁵

The obesity evidence is therefore no longer confined to injection, and 2.4 mg is not the maximum adult injection dose in the current label. The appropriate regimen depends on indication and tolerance, not choosing the largest number. Read the oral Wegovy overview and Wegovy pill cost for the approved tablet route.

Consistency and adherence

There is also a practical, human difference: how easy each form is to stick with. A once-weekly injection is one decision a week, which some people find freeing. A daily tablet is seven decisions a week, each with timing rules attached — and missing or mistiming doses can blunt how well it works. Neither is "better" in the abstract; the right answer is whichever one you will actually take correctly, week after week, because an appropriate treatment needs a routine you can follow. Adherence is one factor in effectiveness, not a promise of a particular weight-loss result.

Which one is right for you?

That is a decision for you and your prescriber, and it depends on what you are treating and how you live. A weekly injection may suit someone who wants the simplest possible routine or whose clinical situation calls for an injection-specific indication. A daily tablet may appeal to someone who would rather not inject, as long as the empty-stomach timing fits their morning. Both are real, FDA-approved, evidence-backed options — not a "real" version and a "lite" version. A few compounded telehealth programs now let you pick the route instead of committing to one — Curex puts the shot and a dissolving tablet on the same plan, Alan Meds splits one molecule four ways across injection, oral tablet and microdose versions of both, and Wellorithm sells both routes and prices its compounded line only after an intake quiz, and Willow starts its dissolving semaglutide tablet at the same monthly price as its weekly shot — though none of those is the FDA-approved product described above. The route choice is not confined to semaglutide, either: one program compounds tirzepatide as a dissolving tablet and charges the same for it as for the injection, which is unusual, because the dual-agonist molecule is otherwise close to injection-only across this field. Where a seller carries both, the price gap between them is usually the tell: the oral version of compounded semaglutide costs two and a half times the injection at Pepti, $249 a month against $99, which is a lot to pay for avoiding a needle in a presentation nobody has run a trial on. Some sellers blur the label as well: EllieMD sells its compounded GLP-1 as oral drops or a shot at one price, but never names the molecule, so ask which drug is in the bottle. Others move further from the label: Wisp's compounded semaglutide comes as drops held under the tongue. Bear in mind that compounded sublinguals and tablets are the least-studied presentations of either drug, so the convenience is real while the evidence behind it is thinner than for the approved products. Cost can also tip the decision; for the injectable brand, our Wegovy cost guide lays out list price, self-pay prices, the savings card, and compounded-semaglutide caveats.

For the full picture of how semaglutide works, what the weight and blood-sugar trials show, and the ongoing-use reality, see our pillar guide: Semaglutide: How It Works, Results & Side Effects.